Press Release

Grand News Network | October 24, 2023

CBO at Tourmaline Bio Acquires Company Stock Options Worth 171,765 Shares

W. Bradford Middlekauff, CBO at Tourmaline Bio (NASDAQ:TRML), reported a large acquisition of company stock options on October 24, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Middlekauff, CBO at Tourmaline Bio, a company in the Health Care sector, was just awarded stock options worth 171,765 shares of TRML. The options give Middlekauff the right to buy the company's stock at $8.32 per share.

Tourmaline Bio shares are trading up 5.71% at $10.0 at the time of this writing on Tuesday morning. Since the current price is $10.0, this makes Middlekauff's 171,765 shares worth $1,717,650.

Now trade stocks ...

Full story available on

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

Disclaimer Press Release Banner

More to read